Daily Roundup

Monday, 14th April 2025
Last updated: 20:00

EGL.ASX ATP.ASX BOT.ASX FID.ASX DRO.ASX

Positive Momentum for Environmental Group Ltd as PFAS Separation Plant Receives EPA Approval

Environmental Group Ltd (EGL) has announced a significant milestone, with its PFAS separation plant receiving approval from the Environmental Protection Agency (EPA) to treat PFAS-contaminated waste at Reclaim Waste's facility. This approval enables Reclaim Waste to accept and process PFAS-contaminated liquid waste, a crucial step in addressing environmental contamination.

The EPA's endorsement is a testament to the effectiveness and safety of EGL's PFAS separation technology, which has been rigorously tested and proven capable of treating PFAS-contaminated waste streams in a safe and sustainable manner. This approval aligns with the new EPA waste disposal regulations set to take effect in March 2025, ensuring Reclaim Waste's compliance with the updated PFAS discharge limits.

Atlas Pearls Shines at Kobe Auction with Strong Sales and Improved Pricing

In other news, Atlas Pearls Ltd (ASX: ATP) has announced the successful completion of its Kobe auction in April 2025. The Company sold 58,345 pearls at an average price of $129 per piece, a notable increase from the previous auction in December 2024. The total revenue generated from the auction was $7.5 million.

Notably, Atlas Pearls' pearls achieved an average index point of 32, up from 21 in the previous auction, indicating improved quality. The $/index point also increased from $3.50 to $4.00, reflecting the market's appreciation for the Company's high-quality pearls.

Atlas Pearls continues to focus on maximizing the value of its pearl production, with plans to expand its customer base, geographic reach, and diversify its sales channels beyond the auction system. The Company is also upgrading its showroom and Pearl Experience Centre in North Bali, expected to open on May 1st, 2025.

Botanix Pharmaceuticals Requests Trading Halt for Capital Raising Announcement

Botanix Pharmaceuticals Ltd (ASX: BOT) has requested a trading halt in its securities, pending the release of an announcement regarding a capital raising. The trading halt is expected to be lifted by the open of trading on April 16, 2025.

Fiducian Group Sees Positive Net Inflows Across Platforms

Fiducian Group Ltd (ASX: FID) has released its Appendix 4C for the quarter ending 31 March 2025, reporting positive net inflows across its core platform and badged platform. The core Fiducian platform saw net inflows of $59 million, while the badged platform and Auxilium fund balance grew to $182 million with $40 million in net inflows.

However, the Company did experience net outflows of $7 million from legacy IFAs during the quarter. Overall, Fiducian Group's Funds Under Management, Administration and Advice stood at $13.9 billion as of 31 March 2025.

Droneshield Secures $32.2 Million in Asia Pacific Military Contracts

Droneshield Ltd (ASX:DRO) has announced a significant contract win, receiving a $32.2 million package of five separate contracts from an Asia Pacific military customer. The delivery and cash payment for these contracts are expected to be completed through the second and third quarters of 2025.

This latest order follows an earlier announcement in January 2025 from the same sophisticated customer, a close military ally of Australia in the Asia Pacific region. The increasing scale and frequency of these orders reflect the growing demand for Droneshield's counter-drone systems as leading customers transition from testing to broader roll-outs.